Choueiri TK - Search Results

1

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy.

Vickers MM, Choueiri TK, Rogers M, Percy A, Finch D, Zama I, Cheng T, North S, Knox JJ, Kollmannsberger C, McDermott DF, Rini BI, Heng DY. Vickers MM, et al. Among authors: choueiri tk. Urology. 2010 Aug;76(2):430-4. doi: 10.1016/j.urology.2009.12.031. Epub 2010 Mar 12. Urology. 2010. PMID: 20223508

2

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Choueiri TK, Bukowski RM, Rini BI. Choueiri TK, et al. Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003. Semin Oncol. 2006. PMID: 17045089 Review.

3

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

4

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

5

Differential expression of caveolin-1 in renal neoplasms.

Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Tamaskar I, et al. Among authors: choueiri tk. Cancer. 2007 Aug 15;110(4):776-82. doi: 10.1002/cncr.22838. Cancer. 2007. PMID: 17594718 Free article.

6

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.

Escudier B, Choueiri TK, Oudard S, Szczylik C, Négrier S, Ravaud A, Chevreau C, Venner P, Champagne P, Croteau D, Dupont E, Hariton C, Bukowski RM. Escudier B, et al. Among authors: choueiri tk. J Urol. 2007 Nov;178(5):1901-5. doi: 10.1016/j.juro.2007.07.035. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868728 Clinical Trial.

7

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Choueiri TK, et al. J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223. J Clin Oncol. 2008. PMID: 18165647

8

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.

Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. Choueiri TK, et al. J Urol. 2008 Mar;179(3):906-10; discussion 910. doi: 10.1016/j.juro.2007.10.059. Epub 2008 Jan 22. J Urol. 2008. PMID: 18207194

9

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies.

Golshayan AR, Brick AJ, Choueiri TK. Golshayan AR, et al. Among authors: choueiri tk. Future Oncol. 2008 Feb;4(1):85-92. doi: 10.2217/14796694.4.1.85. Future Oncol. 2008. PMID: 18241003 Review.

10

Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.

Choueiri TK. Choueiri TK. Clin Genitourin Cancer. 2008 Mar;6(1):15-20. doi: 10.3816/CGC.2008.n.002. Clin Genitourin Cancer. 2008. PMID: 18501077 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

819 results

Search Page

Filters